Auna S.A.: Auna Announces 2Q26 Financial Results
Auna S.A. (NYSE: AUNA) reported 2Q26 results with revenue up 9% FX-neutral to S/1,238 million, but Adjusted EBITDA down 9% FX-neutral to S/227 million. Operating cash flow and free cash flow rose 45% and 181% YoY, respectively. The company attributed EBITDA declines to service mix and cost pressures across its Latin American markets. Auna reaffirmed its full-year revenue guidance of 12% growth and expects Adjusted EBITDA growth at the low end of its 10-14% range.
How this was made
The 30-second read
Why it matters
The key trade input is the combination of (1) revenue growth, (2) EBITDA margin pressure from service mix and accepted billing-related penalties in Peru, and (3) a strong working-capital-driven cash flow rebound that improves leverage toward a sub-3.0x medium-term target. The company also reaffirms FY26 revenue guidance and provides an EBITDA growth expectation toward the low end.
Market read
Traders can update valuation and positioning based on the fresh 2Q26 datapoints and the explicit FY26 revenue and EBITDA outlook framing.
What to watch
The guidance for Adjusted EBITDA is framed as low-end growth and explicitly excludes accepted penalties, so the market may scrutinize whether penalties recur or whether cost inflation (pharmacy, payroll, SG&A) persists into 2H26.
Background
Auna is a Latin America healthcare platform operating in Mexico, Peru, and Colombia, reporting 2Q26 results under IFRS and discussing segment drivers and payor mix.
Ticker impact
Auna reported 2Q26 revenue up 13% YoY and guided FY26 revenue growth near 12% FX-neutral, while Adjusted EBITDA fell on mix and penalties.
Near-term trading likely hinges on whether investors focus on the cash-flow and deleveraging progress versus the EBITDA decline and penalty-driven noise.
The article provides specific 2Q26 KPIs (revenue, Adjusted EBITDA, OCF/FCF, leverage) plus a reaffirmed FY26 revenue guidance and an EBITDA outlook that explicitly reflects temporary cost pressures and excludes accepted penalties.
Market effects
Healthcare services operators in Latin America may see read-across on how risk-sharing (PGP) contract scaling affects margins and working capital.
Peru and Colombia policy and payor mix dynamics are highlighted as influencing predictability and collections, which can affect sentiment toward regional healthcare platforms.
Limited, as the disclosure is company-specific and denominated in Peruvian Soles with FX commentary rather than a global macro shock.
Counterpoint
Investors may discount the EBITDA decline as largely mix and penalty-related, and instead price the deleveraging path and improving collections as the real earnings power signal.
Key entities
- companyAuna S.A.
Announced 2Q26 financial results and reaffirmed FY26 revenue guidance, citing cash-flow strength, leverage improvement, and temporary EBITDA pressure.
